A Randomized controlled trial of the effect of yoga and peer support on glycaemic outcomes in women with type 2 diabetes mellitus: a feasibility study.

Keywords : ['type diabetes mellitus', 'randomized control trial', 'peer support', 'glycaemic outcome', 'feasibility study', 'yoga', 'woman', 'effect']
Author : A Sreedevi
21

Semaglutide once weekly as add-on to SGLT-2 inhibitor therapy in type 2 diabetes (SUSTAIN 9): a randomised, placebo-controlled trial.

Keywords : ['type diabetes sustain', 'randomised placebocontrolle trial', 'inhibitor therapy', 'weekly', 'semaglutide', 'addon']
Author : B Zinman
22

Semaglutide once weekly as add-on to SGLT-2 inhibitor therapy in type 2 diabetes (SUSTAIN 9): a randomised, placebo-controlled trial.

Keywords : ['type diabetes sustain', 'randomised placebocontrolle trial', 'inhibitor therapy', 'weekly', 'semaglutide', 'addon']
Author : B Zinman
22

Semaglutide once weekly as add-on to SGLT-2 inhibitor therapy in type 2 diabetes (SUSTAIN 9): a randomised, placebo-controlled trial.

Keywords : ['type diabetes sustain', 'randomised placebocontrolle trial', 'inhibitor therapy', 'weekly', 'semaglutide', 'addon']
Author : B Zinman
22

Semaglutide once weekly as add-on to SGLT-2 inhibitor therapy in type 2 diabetes (SUSTAIN 9): a randomised, placebo-controlled trial.

Keywords : ['type diabetes sustain', 'randomised placebocontrolle trial', 'inhibitor therapy', 'weekly', 'semaglutide', 'addon']
Author : B Zinman
22

Semaglutide once weekly as add-on to SGLT-2 inhibitor therapy in type 2 diabetes (SUSTAIN 9): a randomised, placebo-controlled trial.

Keywords : ['type diabetes sustain', 'randomised placebocontrolle trial', 'inhibitor therapy', 'weekly', 'semaglutide', 'addon']
Author : B Zinman
22

Semaglutide once weekly as add-on to SGLT-2 inhibitor therapy in type 2 diabetes (SUSTAIN 9): a randomised, placebo-controlled trial.

Keywords : ['type diabetes sustain', 'randomised placebocontrolle trial', 'inhibitor therapy', 'weekly', 'semaglutide', 'addon']
Author : B Zinman
22

Semaglutide once weekly as add-on to SGLT-2 inhibitor therapy in type 2 diabetes (SUSTAIN 9): a randomised, placebo-controlled trial.

Keywords : ['type diabetes sustain', 'randomised placebocontrolle trial', 'inhibitor therapy', 'weekly', 'semaglutide', 'addon']
Author : B Zinman
22

Semaglutide once weekly as add-on to SGLT-2 inhibitor therapy in type 2 diabetes (SUSTAIN 9): a randomised, placebo-controlled trial.

Keywords : ['type diabetes sustain', 'randomised placebocontrolle trial', 'inhibitor therapy', 'weekly', 'semaglutide', 'addon']
Author : B Zinman
22

Semaglutide once weekly as add-on to SGLT-2 inhibitor therapy in type 2 diabetes (SUSTAIN 9): a randomised, placebo-controlled trial.

Keywords : ['type diabetes sustain', 'randomised placebocontrolle trial', 'inhibitor therapy', 'weekly', 'semaglutide', 'addon']
Author : B Zinman
22